article thumbnail

Weekly Cannabis Roundup November 5

Veriheal

Researchers from Eastern Virginia Medical School and Saint Louis University analyzed data across 43 states and found a pattern of arrests associated with cannabis prohibition. The study concluded that the Army “should be less concerned with these recruits if they have no misconduct offenses.”.

History 98
article thumbnail

Media Report: Support for legalising marijuana in Australia nearly doubles over six years. 40% now say yes to personal use

Cannabis Law Report

The nationally representative surveys, last conducted in 2019, have been collating data on drug use and attitudes every two to three years since 1985. A review of the survey data showed that 41.1% in 2001 up to 38.1% of respondents supported the legalisation of cannabis for personal use in 2019 – a significant rise from 25.5%

Media 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Survey Reveals Almost Half of Canada’s MMJ Patients Reduced Their Alcohol and Opioid Consumption

Veriheal

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

article thumbnail

Portuguse medical cannabis exports increase by 600% says new report

Cannabis Law Report

According to the latest data shared by Infarmed, in fact, in the first two months of 2022 alone, 10 tons of cannabis have already been exported , which anticipates another record year. If in 2020 Portugal had sold 4.5 And the growth does not seem to stop.

article thumbnail

Psych Newsletter UK Interviews MP, Crispin Blunt

Cannabis Law Report

The constitutional convention saw the campaign to reschedule psilocybin elevated to national headlines, and a week later British psychedelic company COMPASS Pathways released data from its pivotal Phase IIb trial with psilocybin, which demonstrated its efficacy in treatment-resistant depression.

Policy 52
article thumbnail

Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers

Veriheal

The team peered into the findings of numerous articles published between 2001 and 2019. Once they felt satisfied with their takeaways, they put together specific guidelines featuring data from 70 studies, 51 of which were original studies and 19 of which were systematic reviews.

article thumbnail

Study Indicates Cannabis May Alleviate Neuropathic Pain Caused By Chemotherapy

SpeedWeed

The researchers highlighted the strength of the study, saying it was owed to the “reliability of the data on cannabis use, since all of the participating patients received cannabis by regulated licensure.”. “It View original article.